The video recording of NINR's second Director’s Lecture of 2022 is now available to view. On October 11, 2022, Dr. Chandra Ford, Professor and Founding Director of the Center for the Study of Racism, Social Justice & Health at the UCLA Fielding School of Public Health, and Dr. Suzanne Miyamoto, Chief Executive Officer of the American Academy of Nursing, presented research priorities and the practice and policy implications of nursing research through the health equity lens.
Dr. Chandra L. Ford is Professor of Community Health Sciences and Founding Director of the Center for the Study of Racism, Social Justice and Health in the UCLA Fielding School of Public Health. She is lead editor (with Derek Griffith, Marino Bruce and Keon Gilbert) of Racism: Science & Tools for the Public Health Professional (APHA Press, 2019), which was named an Outstanding Academic Title for 2020 by the American Library Association’s Choice magazine. She earned a doctorate in Health Behavior from the UNC Gillings School of Global Public Health and completed postdoctoral fellowships in Social Medicine (at UNC School of Medicine) and Epidemiology (at Columbia University’s Mailman School of Public Health), the latter as a W. K. Kellogg Foundation Kellogg Health Scholar.
Her work offers conceptual and methodological tools for studying racism as a public health problem. She originated (with Collins Airhihenbuwa) the Public Health Critical Race Praxis, which is an approach for applying Critical Race Theory empirically. Much of her empirical work examines inequities in HIV testing, care and prognoses, or documents barriers to services among LGBTQ survivors of intimate partner violence. Her work has been published in the American Journal of Public Health, the Boston University Law Review, the Du Bois Review, Ethnicity & Disease, JAIDS, Social Science & Medicine, and other peer-reviewed journals.
Dr. Ford has received many teaching awards and several notable honors, including the 2020 Wade Hampton Frost Award from the Epidemiology Section of the American Public Health Association, a Lifetime Achievement Award from the Association of Black Women Physicians, a TrueHero Award from TruEvolution and the 2019 Paul Cornely Award from the Health Activist Dinner group.
Dr. Ford serves the profession extensively. In 2016, she served on the National Academy of Medicine’s Committee on Community-based Solutions to Promote Health Equity in the United States and was named co-chair of the Committee on Science of the American Public Health Association’s Anti-Racism Collaborative. She is a longstanding member of the American College of Epidemiology’s Minority Affairs Committee and a former president of the Society for the Analysis of African American Public Health Issues. In addition, she has been involved with the Black Radical Congress and remains involved with the Black Coalition Fighting Back Serial Murders.
Suzanne Miyamoto, PhD, RN, FAAN is the CEO of the American Academy of Nursing. The Academy’s mission is to improve health and achieve health equity by impacting policy through nursing leadership, innovation, and science. Dr. Miyamoto is highly regarded for her expertise in health care policy as well as her leadership and successful development of advocacy-based coalitions. Prior to her position at the Academy, Dr. Miyamoto served as the American Association of Colleges of Nursing’s Chief Policy Officer. She is member of the National Academy of Medicine’s Leadership Consortium, the National Minority Quality Forum’s Advisory Board, and the Association of American Medical Colleges’ Research and Action Institute External Advisory Committee. Currently, she is on faculty at Georgetown University, School of Nursing. Dr. Miyamoto received her Bachelor of Science in Nursing, Bachelor of Arts in Psychology, Master of Science in Nursing, and Doctorate of Philosophy in Nursing from the University of Michigan, Ann Arbor.
The NINR Director’s Lecture Series brings together top experts from across the nation to share their insights for advancing nursing science with a transdisciplinary audience at the National Institutes of Health (NIH) and the broader biomedical research community. For the 2022-2023 NINR Director’s Lecture Series, each lecture will focus on a different NINR strategic plan research lens.